Martina Roos

Martina Roos is the Co-Founder, CEO, and President of Sardona Therapeutics, a precision oncology company focused on developing small molecules targeting RNA-binding proteins for cancer treatment. With a background in hematology/oncology research and experience as an Assistant Professor at the David Geffen School of Medicine at UCLA, Martina has led research programs and clinical trials aimed at understanding therapy resistance in cancer. Prior to their current role, Martina held positions at the University of California, Los Angeles, and Roche, bringing a wealth of experience in pharmaceutical production and biological chemistry. Martina's educational background includes a Doctor of Science in Pharmaceutical Chemistry and Biology from ETH Zürich, demonstrating their expertise in the field.